Patent · US Expired

HIV-3 retrovirus and its use

US5304466A · kind A · utility

27Cited by

0References

19Claims

0Family size

Assignee

Innogenetics N.V. · BE

Inventors

Robert De Leys · Grimbergen, BE
Bart Vanderborght · Geel, BE
Eric Saman · Bornem, BE
H. Van Heuverswyn · Laarne, BE

Key dates

Filing date	Mar 23, 1990
Grant date	Apr 19, 1994
Priority date	—
Expiry date	Mar 23, 2010

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/809
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is a new retrovirus designated HIV-3 and deposited in the European Collection of Animal Cell Cultures (ECACC) under V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.